Multiple sclerosis

This procedure focuses on addressing the challenges posed by multiple sclerosis, a chronic disease affecting the central nervous system. It aims to improve the quality of life for patients by supporting medical research, enhancing diagnostic tools, and ensuring better access to effective treatments across the EU.

This will primarily affect patients living with multiple sclerosis, healthcare providers, and pharmaceutical researchers seeking to develop new therapies.